| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,064 |
3,371 |
$385K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,709 |
2,950 |
$259K |
| 99215 |
Prolong outpt/office vis |
505 |
448 |
$56K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
230 |
224 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
94 |
90 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,021 |
372 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
21 |
21 |
$303.73 |
| 87899 |
|
21 |
21 |
$166.79 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
479 |
355 |
$61.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
320 |
233 |
$59.21 |
| 99000 |
|
63 |
58 |
$20.52 |
| 99401 |
|
404 |
307 |
$20.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
16 |
16 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
14 |
13 |
$0.00 |